Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.56 |
| ▸ | HTR2B | P41595 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HPGDS | O60760 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6182649 | 0.88 | HPGDS (0.57) | ACHEALDH1A1HDAC1HDAC8HDAC6 | |
| SCHEMBL14564378 | 0.85 | CYP2C9 (0.62) | CYP2C9SCN9AHTR2BACHEALDH1A1 | |
| SCHEMBL1786612 | 0.85 | HSD17B1 (0.60) | CYP2C9SCN9AHTR2BACHEALDH1A1 | |
| SCHEMBL31351001 | 0.84 | TLR7 (0.62) | CYP2C9SCN9AHTR2BACHEALDH1A1 | |
| Hydrochloric Acid SCHEMBL27746131 | 0.82 | TLR7 (0.60) | CYP2C9SCN9AHTR2BACHEALDH1A1 | |
| SCHEMBL168519 | 0.82 | HTR2B (0.66) | CYP2C9SCN9AHTR2BACHEALDH1A1 | |
| SCHEMBL7089339 | 0.79 | GAA (0.51) | CYP2C9SCN9AHTR2BACHEALDH1A1 | |
| SCHEMBL31350850 | 0.79 | MKNK1 (0.53) | CYP2C9SCN9AHTR2BACHEALDH1A1 | |
| SCHEMBL1812154 | 0.76 | HDAC6 (0.70) | CYP2C9ALDH1A1HDAC6CYP2C19TLR7 | |
| SCHEMBL31350948 | 0.76 | HDAC6 (0.70) | CYP2C9ALDH1A1HDAC6CYP2C19TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025003987-A1 | NOVEL CARBOXAMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 동화약품주식회사 | 2025-01-02 | — | — | WO | disclosed |
| US-20030144308-A1 | Fructose 1,6-bisphosphatase inhibitors | BAUER PAUL H (US) | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144308-A1 | Fructose 1,6-bisphosphatase inhibitors | FBP1, HK1, G6PC1 | CYP2C9 598/4885SCN9A 4193/4885HTR2B 2954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.